UK HPV Vaccination Rates Still Lag Behind Pre-Pandemic Levels
The latest UK Health Security Agency (UKHSA) report reveals that HPV vaccine coverage among Year 8 and Year 9 pupils has yet to bounce back to pre-COVID levels. The routine adolescent HPV vaccination programme, mainly delivered in schools, has faced setbacks since the pandemic began.
HPV Vaccine: A Proven Lifesaver Against Cancer
England’s HPV vaccine programme has slashed harmful infections and cervical cancer rates dramatically, especially when given to young teens aged 12 and 13. The vaccine not only protects against cervical cancer but also shields against genital warts, and cancers of the genital areas, anus, and parts of the head and neck.
Offered as a two-dose schedule to all 12 to 13-year-olds in school years 8 and 9, the programme is one of the world’s most successful, boasting millions of doses since 2008.
Vaccine Coverage Dips Amid Pandemic, But Catch-Up Efforts Underway
- Year 8 girls’ HPV vaccine coverage dropped 7%
- Year 8 boys’ coverage fell 8.7% in 2021-2022 compared to the previous academic year
- Uptake improved for Years 9 and 10, showing NHS catch-up progress
- Yet coverage remains below pre-pandemic highs
“The HPV vaccine is available for girls and boys in Year 8 and we encourage everyone eligible to take up this potentially life-saving vaccine when offered,” said Dr Vanessa Saliba, UKHSA Consultant Epidemiologist. “Many young people missed out due to COVID, but while catch-up programmes are underway, more must be done.”
Youngsters who missed their jabs can still get vaccinated up until their 25th birthday via school nurses, immunisation teams, or GP surgeries.
Experts Urge Parents and Teens to Grab the Vaccine
“As a nurse on cancer wards, I’ve witnessed firsthand how HPV vaccination saves lives,” said Minister for Women’s Health Maria Caulfield. “We’re making cervical screening easier and faster, but the vaccine remains vital. If you’re 12 or 13 and offered this jab – take it. It could save your life.”
Samantha Dixon, Chief Executive of Jo’s Cervical Cancer Trust, added: “The evidence is clear: HPV vaccination is stopping young women developing cervical cancer. Around nine women are diagnosed daily in the UK. Don’t miss your chance to be protected. And remember, whether vaccinated or not, cervical screening is crucial.”
HPV Vaccine and Cervical Screening: Both Key to Cancer Prevention
While the HPV vaccine prevents most cervical cancer cases, it doesn’t catch them all. All women aged 25 and over in England are offered cervical screening to spot early signs of disease. Even vaccinated women must attend screening when invited—missing appointments only puts lives at risk.
The message is clear: HPV vaccines save lives, but full protection requires completing the jab programme and attending regular cervical screening.
